Skip to main content

조주연 교수

Ju-Yeon Cho

서울대학교 · 의학

연구실 소개

조주연 교수의 연구실은 간염 바이러스 감염과 간세포암의 발달 메커니즘을 밝히고, 이를 바탕으로 조기 진단 및 개인 맞춤 치료 전략을 개발하는 데 초점을 맞추고 있습니다. 특히, 만성 간염 환자에서의 간세포암 발생 위험 요소 분석과 함께, 대사체 분석을 활용한 조기 간세포암 진단 지표 개발에 주력하고 있으며, 약물 유도성 간 기능 평가 및 항염증 메커니즘 규명을 위한 기초 연구도 진행하고 있습니다. 이는 임상적 적용이 가능한 생물학적 지표 발굴과 신약 개발에 기여할 수 있습니다.

간세포암대사체 분석조기 진단만성 간염약물 대사 평가

연구 현황

논문 수
434
총 인용 수
9,052
최근 5년 논문
57
주요 분야
의학

연구 성과 추이

표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수
57총합
2022
2023
2024
2025
2026
5개년 연도별 피인용 수
411총합
20222023202420252026

주요 논문

15
1
논문|인용수 103·2013
Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance
K‐H Shin, Min‐Ho Choi, K S Lim, K‐S Yu, I-J Jang, Joo‐Youn Cho
SJR Q1FWCI 16.6Clinical Pharmacology & Therapeutics

This study aimed to evaluate endogenous metabolic markers of hepatic cytochrome P450 (CYP)3A activity in healthy subjects using a metabolomics approach. Twenty-four subjects received the following medication during the following three study periods: 1 mg of i.v. midazolam alone (control phase), 1 mg of i.v. midazolam after 4 days of pretreatment with 400 mg of ketoconazole once daily (CYP3A-inhibited phase), and 2.5 mg of i.v. midazolam after 10 days of pretreatment with 600 mg of rifampicin onc

PharmacologyPharmacology, Toxicology and Pharmaceutics
2
논문|인용수 97·2011
Thermoelectric properties and investigations of low thermal conductivity in Ga-doped Cu<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math>GeSe<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msub><mml:mrow/><mml:mn>3</mml:mn></mml:msub></mml:math>
Joo‐Youn Cho, Xun Shi, James R. Salvador, G. P. Meisner, Junjiao Yang, H. Wang, Andrew A. Wereszczak, Xiaowang Zhou, Ctirad Uher
SJR Q1FWCI 3.4Physical Review BOA

In this study, we synthesized a series of low thermal conductivity diamondlike materials with the general formula Cu${}_{2}$Ga${}_{x}$Ge${}_{1\ensuremath{-}x}$Se${}_{3}$ for 0 \ensuremath{\le} $x$ \ensuremath{\le} 0.1, and their transport properties were evaluated to establish their suitability for thermoelectric-based waste heat recovery applications. We report results for the Seebeck coefficient ($S$), electrical resistivity (\ensuremath{\rho}), thermal conductivity (\ensuremath{\kappa}), Hall

Materials ChemistryMaterials Science
3
논문|인용수 93·2016
Neuroprotective Effects of Endurance Exercise Against High‐Fat Diet‐Induced Hippocampal Neuroinflammation
Eun‐Bum Kang, Jung‐Hoon Koo, Yong Chul Jang, Chao Yang, Youngseok Lee, Ludmila Cosío-Lima, Joo‐Youn Cho
SJR Q1FWCI 4.5Journal of Neuroendocrinology

Obesity contributes to systemic inflammation, which is associated with the varied pathogenesis of neurodegenerative diseases. Growing evidence has demonstrated that endurance exercise (EE) mitigates obesity-induced brain inflammation. However, exercise-mediated anti-inflammatory mechanisms remain largely unknown. We investigated how treadmill exercise (TE) reverses obesity-induced brain inflammation, mainly focusing on toll-like receptor-4 (TLR-4)-dependent neuroinflammation in the obese rat bra

NeurologyNeuroscience
4
논문|인용수 76·2019
Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
Da Jung Kim, Eun Ju Cho, Kyung‐Sang Yu, In‐Jin Jang, Jung‐Hwan Yoon, Taesung Park, Joo‐Youn Cho
SJR Q1FWCI 6.5CancersOA

The established biomarker for hepatocellular carcinoma (HCC), serum α-fetoprotein (AFP), has suboptimal performance in early disease stages. This study aimed to develop a metabolite panel to differentiate early-stage HCC from cirrhosis. Cross-sectional metabolomic analyses of serum samples were performed for 53 and 47 patients with early HCC and cirrhosis, respectively, and 50 matched healthy controls. Results were validated in 82 and 80 patients with early HCC and cirrhosis, respectively. To re

EpidemiologyMedicine
5
논문|인용수 71·2016
Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal‐weight adolescents
K. Cho, Jin Soo Moon, Jae‐Heon Kang, Han Byul Jang, H‐J. Lee, S. I. Park, K‐S Yu, Joo‐Youn Cho
SJR Q1FWCI 3.1Pediatric Obesity

Significantly different metabolome signatures were identified between normal-weight and obese adolescents. Combined untargeted and targeted metabolomics demonstrated that inflammation-driven insulin resistance, ammonia toxicity and oxidative stress may represent crucial metabolomic signatures in obese adolescents.

Molecular BiologyBiochemistry, Genetics and Molecular Biology
6
논문|인용수 60·2009
Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation
Joo‐Youn Cho, Dong Wook Kang, Xiaochao Ma, Sung‐Hoon Ahn, Kristopher W. Krausz, Hans Luecke, Jeffrey R. Idle, Frank J. Gonzalez
SJR Q1FWCI 9.2Journal of Lipid ResearchOA

Pregnane X receptor (PXR) is an important nuclear receptor xenosensor that regulates the expression of metabolic enzymes and transporters involved in the metabolism of xenobiotics and endobiotics. In this study, ultra-performance liquid chromatography (UPLC) coupled with electrospray time-of-flight mass spectrometry (TOFMS), revealed altered urinary metabolomes in both Pxr-null and wild-type mice treated with the mouse PXR activator pregnenolone 16alpha-carbonitrile (PCN). Multivariate data anal

PharmacologyPharmacology, Toxicology and Pharmaceutics
7
논문|인용수 50·2002
Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19
Joo‐Youn Cho, Kyung‐Sang Yu, In‐Jin Jang, Byung‐Hwan Yang, Sang‐Goo Shin, Dong‐Seok Yim
SJR Q1FWCI 3.5British Journal of Clinical PharmacologyOA

A single dose of moclobemide resulted in significant suppression of CYP2C19 activity in EMs. We conclude that physicians prescribing moclobemide should pay attention to its pharmacokinetic interactions even on the first day of coadministration with CYP2C19 substrates.

PharmacologyPharmacology, Toxicology and Pharmaceutics
8
논문|인용수 50·2004
HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION
Joo‐Youn Cho, Hyeong-Seok Lim, Jae‐Yong Chung, Kyung‐Sang Yu, Jung-Ryul Kim, Sang-Goo Shin, In‐Jin Jang
SJR Q1FWCI 2.4Drug Metabolism and Disposition
RheumatologyMedicine
9
논문|인용수 45·2000
DETERMINATION OF NUMBER DENSITY, SIZE AND MORPHOLOGY OF AGGREGATES IN COFLOW DIFFUSION FLAMES USING LIGHT SCATTERING AND LOCAL SAMPLING
Joo‐Youn Cho, Moon Kee Choi
SJR Q1FWCI 15.2Journal of Aerosol Science
Water Science and TechnologyEnvironmental Science
10
논문|인용수 44·2009
Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge
Joo‐Youn Cho, Tsutomu Matsubara, Dong Wook Kang, Sung‐Hoon Ahn, Kristopher W. Krausz, Jeffrey R. Idle, Hans Luecke, Frank J. Gonzalez
SJR Q1FWCI 3.0Journal of Lipid ResearchOA

Farnesoid X receptor (FXR) is a nuclear receptor that regulates genes involved in synthesis, metabolism, and transport of bile acids and thus plays a major role in maintaining bile acid homeostasis. In this study, metabolomic responses were investigated in urine of wild-type and Fxr-null mice fed cholic acid, an FXR ligand, using ultra-performance liquid chromatography (UPLC) coupled with electrospray time-of-flight mass spectrometry (TOFMS). Multivariate data analysis between wild-type and Fxr-

OncologyMedicine
11
논문|인용수 44·2016
Metabolomic analysis identifies potential diagnostic biomarkers for aspirin‐exacerbated respiratory disease
Ga‐Young Ban, K. Cho, Seung‐Hyun Kim, Myung Keun Yoon, Jong Hyuk Kim, H. Y. Lee, Yoo Seob Shin, Y.‐M. Ye, Joo‐Youn Cho, Hae‐Sim Park
SJR Q1FWCI 3.5Clinical & Experimental AllergyOA

Serum metabolite level of LTE<sub>4</sub> and LTE<sub>4</sub> /PGF<sub>2</sub> α ratio was identified as potential in vitro diagnostic biomarkers for AERD using the UHPLC/Q-ToF MS system, which were closely associated with major pathogenetic mechanisms underlying AERD.

PhysiologyMedicine
12
논문|인용수 40·2021
Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids
Yujin Lee, Andrew HyoungJin Kim, Eunwoo Kim, SeungHwan Lee, Kyung‐Sang Yu, In‐Jin Jang, Jae‐Yong Chung, Joo‐Youn Cho
SJR Q1FWCI 3.6Diabetes Research and Clinical PracticeOA
PhysiologyMedicine
13
논문|인용수 38·2022
An Improved Method to Quantify Short-Chain Fatty Acids in Biological Samples Using Gas Chromatography–Mass Spectrometry
Kyeong-Seog Kim, Yujin Lee, Woori Chae, Joo‐Youn Cho
SJR Q2FWCI 2.7MetabolitesOA

Gut microbial metabolites, short-chain fatty acids (SCFAs), are found at multiple locations in the host body and are identified as important metabolites in gut microbiome-associated diseases. Quantifying SCFAs in diverse biological samples is important to understand their roles in host health. This study developed an accurate SCFA quantification method by performing gas chromatography-mass spectrometry (GC/MS) in human plasma, serum, feces, and mouse cecum tissue. The samples were acidified with

Molecular BiologyBiochemistry, Genetics and Molecular Biology
14
논문|인용수 35·2014
Effects of <scp>HM30181</scp>, a <scp>P</scp>‐glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers
Tae‐Eun Kim, Howard Lee, Kyoung Soo Lim, SeungHwan Lee, S.-S. Yoon, Kyung‐Mi Park, Hyesun Han, Sang‐Goo Shin, In‐Jin Jang, Kyung‐Sang Yu, Joo‐Youn Cho
SJR Q1FWCI 1.6British Journal of Clinical PharmacologyOA

HM30181 inhibits P-gp mainly in the intestinal endothelium, which can be beneficial because pan-inhibition of P-gp, particularly in the brain, could lead to detrimental adverse events. Further studies are warranted to investigate adequately the dose-exposure relationship of HM30181, along with its duration of effect.

OncologyMedicine
15
논문|인용수 33·2011
The Effect of the Newly Developed Angiotensin Receptor II Antagonist Fimasartan on the Pharmacokinetics of Atorvastatin in Relation to OATP1B1 in Healthy Male Volunteers
Kwang-Hee Shin, Tae‐Eun Kim, Sung Eun Kim, Min Goo Lee, Im‐Sook Song, Seo Hyun Yoon, Joo‐Youn Cho, In‐Jin Jang, Sang-Goo Shin, Kyung‐Sang Yu
SJR Q2FWCI 1.7Journal of Cardiovascular PharmacologyOA

We showed that fimasartan raised plasma atorvastatin concentrations. In vitro tests suggested that this effect may have been mediated by fimasartan inhibition of organic anion-transporting polypeptide 1B1.

OncologyMedicine

대표 연구 분야

Molecular BiologyPharmacologyOncologyComputer Networks and CommunicationsEndocrinology, Diabetes and MetabolismInformation Systems

조주연 교수의 연구를 Nubint에서 더 깊이 살펴보세요

이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.